{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:14:12Z","timestamp":1791332052639,"version":"4.3.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12353-9","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:01:45Z","timestamp":1765803705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adherence to isoniazid and rifapentine preventive therapy for better treatment outcomes among adults living with HIV in public health facilities in Addis Ababa: a multicenter study"],"prefix":"10.1186","volume":"26","author":[{"given":"Kalkidan","family":"Yae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firaol Regea","family":"Gelassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenealem","family":"Gezahegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfu","family":"Zewdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geda","family":"Edea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyob","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailu","family":"Merga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"23","key":"12353_CR1","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, et al. Three months of weekly rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365(23):2155\u201366. https:\/\/doi.org\/10.1056\/NEJMoa1104875.","journal-title":"N Engl J Med"},{"key":"12353_CR2","unstructured":"World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization. 2015. Available from: https:\/\/www.who.int\/tb\/publications\/latent-tuberculosis-infection\/en\/"},{"key":"12353_CR3","unstructured":"World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization. 2020. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240063449"},{"issue":"1","key":"12353_CR4","doi-asserted-by":"publisher","first-page":"e100268","DOI":"10.1136\/bmjhci-2020-100268","volume":"28","author":"KD Gashu","year":"2021","unstructured":"Gashu KD, Gelaye KA, Lester R, Tilahun B. Effect of a phone reminder system on patient-centered tuberculosis treatment adherence among adults in Northwest ethiopia: a randomized controlled trial. BMJ Health Care Inf. 2021;28(1):e100268. https:\/\/doi.org\/10.1136\/bmjhci-2020-100268.","journal-title":"BMJ Health Care Inf"},{"issue":"6","key":"12353_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1521\/aeap.2014.26.6.521","volume":"26","author":"L Beer","year":"2014","unstructured":"Beer L, Skarbinski J. Adherence to antiretroviral therapy among HIV-infected adults in the united States. AIDS Educ Prev. 2014;26(6):521\u201337. https:\/\/doi.org\/10.1521\/aeap.2014.26.6.521.","journal-title":"AIDS Educ Prev"},{"key":"12353_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12879-022-07432-7","volume":"22","author":"KD Gashu","year":"2022","unstructured":"Gashu KD, Tsegaye AT, Gelaye KA, et al. Adherence to tuberculosis preventive therapy among people living with HIV: a multicenter study in Ethiopia. BMC Infect Dis. 2022;22:401. https:\/\/doi.org\/10.1186\/s12879-022-07432-7.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"12353_CR7","doi-asserted-by":"publisher","first-page":"e0235000","DOI":"10.1371\/journal.pone.0235000","volume":"15","author":"M Tesfaye","year":"2020","unstructured":"Tesfaye M, Soboka M, Adorjan K, et al. Factors associated with adherence to tuberculosis preventive therapy among HIV-positive adults in addis Ababa. PLoS ONE. 2020;15(7):e0235000. https:\/\/doi.org\/10.1371\/journal.pone.0235000.","journal-title":"PLoS ONE"},{"issue":"10","key":"12353_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.5588\/ijtld.19.0121","volume":"23","author":"G Mengistu","year":"2019","unstructured":"Mengistu G, Alemayehu T, Gelaw B, et al. Adherence to tuberculosis preventive therapy among people living with HIV in Northwest Ethiopia. Int J Tuberc Lung Dis. 2019;23(10):1081\u20137. https:\/\/doi.org\/10.5588\/ijtld.19.0121.","journal-title":"Int J Tuberc Lung Dis"},{"key":"12353_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1186\/s12889-018-5934-6","volume":"18","author":"MF Bwambale","year":"2018","unstructured":"Bwambale MF, Ssengooba W, Muganzi A, et al. Adherence to tuberculosis preventive therapy among HIV-positive adults in Kampala, Uganda. BMC Public Health. 2018;18:1020. https:\/\/doi.org\/10.1186\/s12889-018-5934-6.","journal-title":"BMC Public Health"},{"issue":"1","key":"12353_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5588\/ijtld.19.0410","volume":"24","author":"R Musoke","year":"2020","unstructured":"Musoke R, Nakakeeto M, Ssengooba W, et al. Adherence to three-month weekly rifapentine and isoniazid preventive therapy in Uganda. Int J Tuberc Lung Dis. 2020;24(1):60\u20137. . https:\/\/doi.org\/10.5588\/ijtld.19.0410","journal-title":"Int J Tuberc Lung Dis"},{"key":"12353_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12879-018-3325-0","volume":"18","author":"SG Abdissa","year":"2018","unstructured":"Abdissa SG, Tafere G, Tessema B, et al. Adherence to TB preventive therapy among adults in Dilla, Southern Ethiopia. BMC Infect Dis. 2018;18:383. https:\/\/doi.org\/10.1186\/s12879-018-3325-0.","journal-title":"BMC Infect Dis"},{"key":"12353_CR12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1186\/s12879-019-4266-2","volume":"19","author":"GM Kassa","year":"2019","unstructured":"Kassa GM, Alemu TW, Desalegn GG, et al. Adherence to isoniazid preventive therapy among people living with HIV in Adama, Ethiopia. BMC Infect Dis. 2019;19:644. https:\/\/doi.org\/10.1186\/s12879-019-4266-2.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"12353_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4103\/ijmy.ijmy_27_20","volume":"9","author":"B Taye","year":"2020","unstructured":"Taye B, Tesfaye M, Alemayehu H. Adherence to tuberculosis preventive therapy among HIV-positive adults in Gambella, Ethiopia. Int J Mycobacteriol. 2020;9(2):160\u20136. https:\/\/doi.org\/10.4103\/ijmy.ijmy_27_20.","journal-title":"Int J Mycobacteriol"},{"key":"12353_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12889-017-4413-7","volume":"17","author":"C Munthali","year":"2017","unstructured":"Munthali C, Nyirenda T, Chirwa T, et al. Adherence to TB preventive therapy among HIV-infected adults in Malawi. BMC Public Health. 2017;17:536. https:\/\/doi.org\/10.1186\/s12889-017-4413-7.","journal-title":"BMC Public Health"},{"issue":"3","key":"12353_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5588\/ijtld.18.0367","volume":"23","author":"JM Kioko","year":"2019","unstructured":"Kioko JM, Mwangi J, Kaguthi G. Adherence to isoniazid preventive therapy in Kenya. Int J Tuberc Lung Dis. 2019;23(3):345\u201352. https:\/\/doi.org\/10.5588\/ijtld.18.0367.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"12353_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5588\/ijtld.19.0647","volume":"24","author":"R Subbaraman","year":"2020","unstructured":"Subbaraman R, Devaleenal B, Das J, et al. Adherence to 3HP preventive therapy in South Africa. Int J Tuberc Lung Dis. 2020;24(2):170\u20137. https:\/\/doi.org\/10.5588\/ijtld.19.0647.","journal-title":"Int J Tuberc Lung Dis"},{"key":"12353_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s11524-018-0228-5","volume":"95","author":"J Bracero-Miranda","year":"2018","unstructured":"Bracero-Miranda J, Robison T, Santiago K. Adherence to tuberculosis preventive therapy among high-risk populations in new York City. J Urban Health. 2018;95:412\u201323. https:\/\/doi.org\/10.1007\/s11524-018-0228-5.","journal-title":"J Urban Health"},{"key":"12353_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12879-020-05206-x","volume":"20","author":"A Chowdhury","year":"2020","unstructured":"Chowdhury A, Khan MS, Islam M. Adherence to 3HP therapy among adults in Bangladesh. BMC Infect Dis. 2020;20:495. https:\/\/doi.org\/10.1186\/s12879-020-05206-x.","journal-title":"BMC Infect Dis"},{"key":"12353_CR19","doi-asserted-by":"publisher","first-page":"e0251732","DOI":"10.1371\/journal.pone.0251732","volume":"16","author":"R Shrestha","year":"2021","unstructured":"Shrestha R, Thapa P, Koirala S. Adherence to TB preventive therapy in nepal: a cohort study. PLoS ONE. 2021;16:e0251732. https:\/\/doi.org\/10.1371\/journal.pone.0251732.","journal-title":"PLoS ONE"},{"key":"12353_CR20","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12879-022-07490-3","volume":"22","author":"TT Gebremariam","year":"2022","unstructured":"Gebremariam TT, Engeda EH, Emiru YK, et al. Predictors of adherence to 3HP preventive therapy among adults living with HIV in Ethiopia. BMC Infect Dis. 2022;22:450. https:\/\/doi.org\/10.1186\/s12879-022-07490-3.","journal-title":"BMC Infect Dis"},{"key":"12353_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13011-020-00293-1","volume":"15","author":"FW Ayele","year":"2020","unstructured":"Ayele FW, Abebe G, Teklay G, et al. Substance use and its effect on adherence to TB preventive therapy among PLHIV in Ethiopia. Subst Abuse Treat Prev Policy. 2020;15:48. https:\/\/doi.org\/10.1186\/s13011-020-00293-1.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"12353_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1186\/s12879-019-4379","volume":"19","author":"F Reza","year":"2019","unstructured":"Reza F, Ahmed S, Siddiqui R. Effect of ART discontinuation history on adherence to TB preventive therapy in Ethiopia. BMC Infect Dis. 2019;19:789. https:\/\/doi.org\/10.1186\/s12879-019-4379-.","journal-title":"BMC Infect Dis"},{"key":"12353_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12913-018-2889-1","volume":"18","author":"B Taye","year":"2018","unstructured":"Taye B, Alemayehu H, Tesfaye M. Health system-related factors and TB preventive therapy adherence in Ethiopia. BMC Health Serv Res. 2018;18:102. https:\/\/doi.org\/10.1186\/s12913-018-2889-1.","journal-title":"BMC Health Serv Res"},{"key":"12353_CR24","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1186\/s12879-021-06603-9","volume":"21","author":"TT Gebremariam","year":"2021","unstructured":"Gebremariam TT, Ayele FW, Emiru YK, et al. Association of long waiting times and adherence to 3HP among adults living with HIV. BMC Infect Dis. 2021;21:879. https:\/\/doi.org\/10.1186\/s12879-021-06603-9.","journal-title":"BMC Infect Dis"},{"key":"12353_CR25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12879-020-05137-3","volume":"20","author":"M Tesfaye","year":"2020","unstructured":"Tesfaye M, Alemayehu H, Taye B, et al. Side effects and adherence to 3HP therapy among HIV-positive adults in addis Ababa. BMC Infect Dis. 2020;20:356. https:\/\/doi.org\/10.1186\/s12879-020-05137-3.","journal-title":"BMC Infect Dis"},{"key":"12353_CR26","doi-asserted-by":"publisher","first-page":"e0255638","DOI":"10.1371\/journal.pone.0255638","volume":"16","author":"KD Gashu","year":"2021","unstructured":"Gashu KD, Gelaye KA, Tsegaye AT. Adherence to 3HP preventive therapy among HIV-infected adults in Northwest ethiopia: a cross-sectional study. PLoS ONE. 2021;16:e0255638. https:\/\/doi.org\/10.1371\/journal.pone.0255638.","journal-title":"PLoS ONE"},{"key":"12353_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12879-020-05206-x","volume":"20","author":"A Chowdhury","year":"2020","unstructured":"Chowdhury A, Khan MS, Islam M. Adherence to TB preventive therapy in Bangladesh. BMC Infect Dis. 2020;20:495. https:\/\/doi.org\/10.1186\/s12879-020-05206-x.","journal-title":"BMC Infect Dis"},{"key":"12353_CR28","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1186\/s12889-018-5934-6","volume":"18","author":"MF Bwambale","year":"2018","unstructured":"Bwambale MF, Ssengooba W, Muganzi A, et al. Adherence to TB preventive therapy among HIV-positive adults in Kampala, Uganda. BMC Public Health. 2018;18:1020. https:\/\/doi.org\/10.1186\/s12889-018-5934-6.","journal-title":"BMC Public Health"},{"key":"12353_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12879-022-07432-7","volume":"22","author":"G Mengistu","year":"2022","unstructured":"Mengistu G, Alemayehu T, Gelaw B, et al. Adherence to tuberculosis preventive therapy among people living with HIV: a multicenter study in Ethiopia. BMC Infect Dis. 2022;22:401. https:\/\/doi.org\/10.1186\/s12879-022-07432-7.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12353-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12353-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12353-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:33:10Z","timestamp":1768815190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12353-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12353"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12353-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Jimma University Institute of Health Institutional Review Board before its commencement. A permission letter was obtained from the Addis Ababa health bureau and each health facility included in the study. The aim of the study was explained to the respondents, and informed written consent was obtained from them.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}